Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alarming dendritic cells for Th2 induction.

Andrew S MacDonald1, Rick M Maizels

  • 1the Institute of Immunology and Infection Research, Ashworth Laboratories, University of Edinburgh, Edinburgh EH9 3JT, Scotland, UK. andrew.macdonald@ed.ac.uk

The Journal of Experimental Medicine
|January 16, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel soil-derived Mycolicibacterium decreases anxiety-like defensive behavioral responses in association with decreases in biomarkers of neuroinflammation and hippocampal microglial priming in adult male rats.

Brain, behavior, and immunity·2026
Same author

Decoding the Mechanism of Action of a Parasite TGFβ Antagonist Inspires the Creation of Cell-Type-Specific TGFβ Modulators.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Use of a cytochrome P450 humanized mouse model to refine schistosomiasis drug discovery.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Molecular Engineering of the Helminth TGF-β Mimetics, TGM1 and TGM4, Reveals a Novel Antagonist of TGF-β Signaling in Fibroblasts.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Decoding the Mechanism of Action of a Parasite TGFβ antagonist Inspires the Creation of Cell-type-specific TGFβ Modulators.

bioRxiv : the preprint server for biology·2026
Same author

Structural and functional analysis of the TGF-β mimic, TGM-2: an immunomodulatory helminth protein.

Genes and immunity·2025
Same journal

Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

The Journal of experimental medicine·2026
Same journal

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

The Journal of experimental medicine·2026
Same journal

Flawed translation triggers oncogenic B-T cell communication.

The Journal of experimental medicine·2026
Same journal

Correction: LCK'ed in: Inborn errors of immunity in LCK reveal how TCR signaling is calibrated.

The Journal of experimental medicine·2026
Same journal

Mechanobiology of inflammation: Pulling the strings of innate immunity.

The Journal of experimental medicine·2026
Same journal

Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis.

The Journal of experimental medicine·2026
See all related articles

Understanding how dendritic cells (DCs) drive T helper type 2 (Th2) immune responses is crucial for treating immune-mediated diseases. Recent discoveries of endogenous tissue factors are advancing Th2 induction by DCs.

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Pathogen-induced T helper type 1 (Th1) responses mediated by dendritic cells (DCs) are well-understood.
  • Mechanisms underlying DC-elicited T helper type 2 (Th2) responses remain largely unknown.
  • This knowledge gap hinders therapeutic development for immune-mediated conditions.

Discussion:

  • Novel endogenous tissue factors are being identified as key regulators of DC function.
  • These factors demonstrate potential in enhancing Th2 cell induction by DCs.
  • Understanding these factors is critical for modulating immune responses.

Key Insights:

  • Progress is being made in elucidating the mechanisms of Th2 induction by DCs.
  • Identification of specific endogenous factors offers new therapeutic targets.

Related Experiment Videos

  • Bridging the knowledge gap in Th2 immunity is essential.

    • Outlook:

    • Further research into endogenous tissue factors will refine strategies for immune-mediated disease therapies.
    • Targeting DC-mediated Th2 responses holds promise for treating allergic and autoimmune diseases.
    • This field is vital for advancing immunomodulatory drug discovery.